نتایج جستجو برای: hemophilia a

تعداد نتایج: 13433047  

Journal: :iranian journal of blood and cancer 0
esfahani h bazmamoun h

background: hemophilia a and b are the most frequent congenital coagulation disorders. this study was conducted to determine the prevalence of hepatitis b, c and human immunodeficiency viruses among hemophilic patients in hamadan, iran. patients and methods: in this study, patients with hemophilia a and b treated in hamedan hemophilia center, hamedan, iran, were screened for hepatitis b, c and ...

2017
Petros Ioannou Emmanouela Tsagkaraki Constantinos Tsioutis Maria Devetzoglou Irene Xylouri Achilleas Gikas Symeon Panagiotakis

Acquired hemophilia is a rare but potentially fatal clinical condition requiring clinical suspicion to reach to a diagnosis, especially in elder patients. This diagnosis should be suspected in patients that present with unexplained persistent bleeding from skin, soft tissues, and mucosa and have a prolonged aPTT.

Beheshtipoor N, Edraki M, Ghanavati Sh, Haghpanah S, Karimi M,

Background: Hemophilia is a chronic bleeding disease and can interfere with daily performance of children. These children require continuous training to prevent bleeding. Since children nurses play an important role in the education of sick children and their self-efficacy and the increase use of educational computer games, the use of educational games for teaching self-efficacy to children wit...

Journal: :journal of cellular and molecular anesthesia 0
taregh bamedi department of parasitology, iranshahr university of medical sciences, iranshahr, iran ghazaleh dadashizadeh department of hematology and blood transfusion, school of medicine, mashhad university of medical sciences, mashhad, iran afsaneh sarabandi department of nursing, faculty of medical sciences, islamic azad university, zahedan branch, zahedan, iran shadi tabibian department of hematology and blood transfusion, school of allied medicine, iran university of medical sciences, tehran, iran mahmood shams department of laboratory sciences, paramedical faculty, babol university of medical sciences, babol akbar dorgalaleh department of hematology and blood transfusion, school of allied medicine, iran university of medical sciences, tehran, iran

inhibitor development is a lifelong challenge for patients with bleeding disorders who received replacement therapy. most commonly, inhibitor formation was observed in hemophilia a patients but patients with rare bleeding disorders (rbd) especially patients with deficiency of factor xiii (fxiii) and factor v (fv) can develop an inhibitor against exogenous factors. several factors considered as ...

Journal: :GSC Advanced Research and Reviews 2023

Hemophilia is an inherited bleeding disorder caused by the lack of a protein necessary for blood clotting. Gene therapy hemophilia involves introduction healthy gene into patient's cells to produce missing protein. There are two main types hemophilia: ex vivo therapy, which extraction from patient, these in laboratory, and reintroduction modified patient; direct delivery body using viral vector...

Journal: :iranian journal of blood and cancer 0
beheshtipoor n ghanavati sh edraki m karimi m haghpanah s

background: hemophilia is a chronic bleeding disease and can interfere with daily performance of children. these children require continuous training to prevent bleeding. since children nurses play an important role in the education of sick children and their self-efficacy and the increase use of educational computer games, the use of educational games for teaching self-efficacy to children wit...

Journal: :iranian journal of public health 0
d.d. farhud

a group of iranian patients suffering from factor viii deficiency (hemophilia a) and treated with contaminated coagulation factor (imported), became seropositive as determined by elisa method. sixty of these individuals, which were available, were studied for abo distribution. the b blood group in anti hiv pos. individuals (13.33%) shows a significant decrease in comparison with the total (1504...

Journal: :Nucleic acids research 1991
F Giannelli P M Green K A High S Sommer D P Lillicrap M Ludwig K Olek P H Reitsma M Goossens A Yoshioka

F.Giannelli, P.M.Green, K.A.High, S.Sommer, D.P.Lillicrap, M.Ludwig, K.OIek, P.H.Reitsma, M.Goossens, A.Yoshioka and G.G.Brownlee* Paediatric Research Unit, Guy's Tower, London Bridge, London SE1 9RT, UK, School of Medicine, Division of Hematology, University of North Carolina, Chapel Hill, NC 27599, Mayo Clinic, 200 Southwest First Street, Rochester, MN 55905, USA, department of Pathology, Ric...

Journal: :Haemophilia : the official journal of the World Federation of Hemophilia 2002
R C R Ljung

Prophylactic treatment of haemophilia has been gaining acceptance as the optimal therapeutic option in an increasing number of haemophilia centres in the developed world in recent years. This paper focus on three aspects of prophylactic therapy: when to start treatment, venous access and the dose/dose interval. Evidence is in favour of prophylactic treatment to be started at an early age using ...

2009
Anne F. Riddell Keith Gomez Carolyn M. Millar Gillian Mellars Saher Gill Simon A. Brown Megan Sutherland Mike A. Laffan Thomas A.J. McKinnon Katharine Dormandy

Katharine Dormandy Haemophilia Centre and Thrombosis Unit, The Royal Free and University College Medical School, London NW3 2QG, United Kingdom. Department of Haematology, Imperial College Academic Health Sciences Centre, Hammersmith Hospital, London W12 0NN, United Kingdom Department of Haematology, Royal Children’s Hospital and Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Austra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید